Command Palette

Search for a command to run...

ALPA
94.74(+0.43%)
1W: -1.11%

Peers

Snapshot Summary

Alpa Laboratories Ltd. shows competitive metrics within the Pharmaceuticals & Drugs sector, particularly with a low PE ratio and solid profitability indicators, suggesting it is an undervalued player. However, it lags in growth compared to top performers in the sector, indicating potential for improvement.

  • • Alpa Laboratories has a low PE ratio of 10.27, indicating undervaluation relative to peers.
  • • It boasts a reasonable ROE of 11.71%, contributing to its profitability.
  • • Revenue growth is modest at 3.41% YoY, suggesting less aggressive expansion than competitors.
  • • Dr. Reddy's Laboratories Ltd.: Highest profitability with strong ROE and growth metrics.
  • • Cipla Ltd.: Strong revenue growth and operational efficiency with solid margins.
  • • Mankind Pharma Ltd.: Best revenue growth trajectory and efficiency in returns.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
ALPA₹96.05₹202.09Cr10.2714.31%0.03
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02
Explore
Watchlists
Chat
Portfolio